Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Myriam Drysdale, PhD

GSK, United Kingdom

Disclosure(s): GlaxoSmithKline: Employee, GlaxoSmithKline GSK shareholder

Poster(s):

1145 - Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 in the US
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET